Home › NDC Lookup › RxCUI directory › RxCUI 389242

Deferiprone 500 MG Oral Tablet — RxCUI 389242

RxNorm drug concept · Semantic clinical drug
RxCUI 389242 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI389242
Official nameDeferiprone 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdeferiprone 500 MG Three-Times-A-Day Oral Tablet
FDA products mapped7
Package NDCs mapped8
Reported Medicaid activity (SDUD)1,767 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Deferiprone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Your body has built up too much iron from the blood transfusions you've needed. That extra iron can slowly damage organs like your heart and liver. Deferiprone works by latching on...
  • What exactly is deferiprone doing in my body?
  • Deferiprone can cause a serious drop in white blood cells — the cells that fight infection. This is the biggest risk with the medication, and it can happen without warning symptoms...
  • Why do I need so many blood tests while taking this?
📖 Read our full Deferiprone guide →

🕸️ Concept Web — How Deferiprone 500 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Deferiprone 500 MG Oral Tablet RxCUI 389242

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Deferiprone 11645
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Ferriprox 1190352
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Deferiprone Oral Tablet 393424
    • Deferiprone Oral Product 1157198
    • Deferiprone Pill 1157199
    • Deferiprone Oral Tablet [Ferriprox] 1190354
    • Ferriprox Oral Product 1190355
    • Ferriprox Pill 1190356
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Deferiprone 500 MG SCDC · 393423
  • Deferiprone Oral Tablet SCDF · 393424
  • Deferiprone Oral Product SCDG · 1157198
  • Deferiprone Pill SCDG · 1157199

Brand-Name Concepts

  • Deferiprone 500 MG Oral Tablet [Ferriprox] SBD · 1190357
  • Deferiprone 500 MG [Ferriprox] SBDC · 1190353
  • Deferiprone Oral Tablet [Ferriprox] SBDF · 1190354
  • Ferriprox Oral Product SBDG · 1190355
  • Ferriprox Pill SBDG · 1190356
  • Ferriprox BN · 1190352

📦 FDA Products & Package NDCs

7 products · 8 package NDCs
8 package NDCs map to RxCUI 389242 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00054-0576-25 100 TABLET, COATED in 1 BOTTLE (0054-0576-25) Deferiprone Hikma Pharmaceuticals USA Inc. 2021-06-03
10122-0103-05 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (10122-103-05) FERRIPROX Chiesi USA, Inc. 2019-08-01
10122-0104-01 50 TABLET in 1 BLISTER PACK (10122-104-01) FERRIPROX Chiesi USA, Inc. 2020-05-19
10122-0104-05 50 TABLET in 1 BOTTLE, PLASTIC (10122-104-05) FERRIPROX Chiesi USA, Inc. 2021-12-01
51672-4196-01 100 TABLET in 1 BOTTLE (51672-4196-1) Deferiprone Sun Pharmaceutical Industries, Inc. 2024-02-05
51672-4237-04 50 TABLET in 1 BOTTLE (51672-4237-4) Deferiprone Sun Pharmaceutical Industries, Inc. 2024-02-05
75907-0348-50 50 TABLET, COATED in 1 BOTTLE (75907-348-50) DEFERIPRONE DR. REDDY'S LABORATORIES, INC. 2025-12-15
75907-0349-01 100 TABLET, COATED in 1 BOTTLE (75907-349-01) DEFERIPRONE DR. REDDY'S LABORATORIES, INC. 2025-12-15
Observed labelers: Chiesi USA, Inc. (3) · DR. REDDY'S LABORATORIES, INC. (2) · Sun Pharmaceutical Industries, Inc. (2) · Hikma Pharmaceuticals USA Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.